DIA/FDA Oligonucleotide-Based Therapeutics Conference
Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.
Thank you for your interest in exhibiting with DIA at the Oligonucleotide-based Therapeutics Conference. The exhibit and marketing opportunities are now available.
- CMIC, INC.
- Nitto Denko Avecia Inc.
- Agilent Technologies, Inc.
- Wave Life Sciences